Azithromycin does not improve disease course in hospitalized infants with respiratory syncytial virus (RSV) lower respiratory tract disease: A randomized equivalence trial

Pediatric Pulmonology

Volumn 43, Issue 2, 2008, Pages 142-149

  Kneyber, Martin C J ^a,b   Van Woensel, Job B M ^c   Uijtendaal, Esther ^d   Uiterwaal, Cuno S P M ^d   Kimpen, Jan L L ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EMMA CHILDREN S HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibiotics; Children; Randomized controlled trial; RSV

Indexed keywords

AZITHROMYCIN; PLACEBO;

ANTIBIOTIC THERAPY; ARTICLE; BREATHING RATE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DEMOGRAPHY; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; INFANT; LABORATORY TEST; LOWER RESPIRATORY TRACT INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIODIAGNOSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ANTIVIRAL AGENTS; AZITHROMYCIN; CHI-SQUARE DISTRIBUTION; DOUBLE-BLIND METHOD; ENTERAL NUTRITION; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; INTUBATION, GASTROINTESTINAL; LENGTH OF STAY; MALE; OXYGEN; PATIENT SELECTION; REFERRAL AND CONSULTATION; RESEARCH DESIGN; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; THERAPEUTIC EQUIVALENCY;

EID: 39449110185     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.20748     Document Type: Article

References (42)

1. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001;344:1917-1928.
2. Kneyber MC, Moll HA, de Groot R. Treatment and prevention of respiratory syncytial virus infection. Eur J Pediatr 2000;159:399-411.
3. Brand PLP, Vaessen-Verberne AAPH. Differences in management of bronchiolitis between hospitals. Eur J Pediatr 2000;159:343-347.
4. Purcell K, Fergie J. Driscoll Children's Hospital respiratory syncytial virus database: Risk factors, treatment and hospital course in 3308 infants and young children, 1991 to 2002. Pediatr Infect Dis J 2004;23:418-423.
5. Vogel AM, Lennon DR, Harding JE, Pinnock RE, Graham DA, Grimwood K, Pattemore PK. Variations in bronchiolitis management between five New Zealand hospitals: Can we do better? J Paediatr Child Health 2003;39:40-45.
6. Antonow JA, Hansen K, McKinstry CA, Byington CL. Sepsis evaluations in hospitalized infants with bronchiolitis. Pediatr Infect Dis J 1998;17:231-236.
7. Bloomfield P, Dalton D, Karleka A, Kesson A, Duncan G, Isaacs D. Bacteraemia and antibiotic use in respiratory syncytial virus infections. Arch Dis Child 2004;89:363-367.
8. Greenes DS, Harper MB. Low risk of bacteremia in febrile children with recognizable viral syndromes. Pediatr Infect Dis J 1999;18:258-261.
9. Hall CB, Powell KR, Schnabel KC, Gala CL, Pincus PH. Risk of secondary bacterial infection in infants hospitalised with respiratory syncytial virus infection. J Pediatr 1988;113:266-271.
10. Korppi M, Leionen M, Koskela M, Makela H, Launiala K. Bacterial coinfection in children hospitalised with respiratory syncytial virus infections. Pediatr Infect Dis J 1989; 8.
11. Kuppermann N, Bank DE, Walton EA, Senac MO, McCaslin I. Risks for bacteremia and urinary tract infections in young febrile children with bronchiolitis. Arch Pediatr Adolesc Med 1997;151: 1207-1214.
12. Liebelt EL, Qi K, Harvey K. Diagnostic testing for serious bacterial infections in infants aged 90 days or younger with bronchiolitis. Arch Pediatr Adolesc Med 1999;153:525-530.
13. Purcell K, Fergie J. Concurrent serious bacterial infections in 2396 infants and children hospitalised with respiratory syncytial virus lower respiratory tract infections. Arch Pediatr Adolesc Med 2002;156:322-324.
14. Purcell K, Fergie J. Concurrent serious bacterial infections in 912 infants and children hospitalized for treatment of respiratory syncytial virus lower respiratory tract infection. Pediatr Infect Dis J 2004;23:267-269.
15. Barlow G, Nathwani D. Is antibiotic resistance a problem? A practical guide for hospital clinicians. Postgrad Med J 2005;81:680-692.
16. Christensen E. Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol 2007;46:947-954.
17. Ferwerda A, Moll HA, Hop WC, Kouwenberg JM, Tjon Pian Gi CV, Robben SG, de GR. Efficacy, safety and tolerabilily of 3 day azithromycin versus 10 day co-amoxiclav in the treatment of children with acute lower respiratory tract infections. J Antimicrob Chemother 2001;47:441-446.
18. Culic O, Erakovic V, Parnham MJ. Anti-inflammatory effects of macrolide antibiotics. Eur J Pharmacol 2001;429:209-229.
19. Simpson W, Hacking PM, Court SD, Gardner PS. The radiological findings in respiratory syncytial virus infection in children. Part I. Definitions and interobserver variation in the assessment of abnormalities on the chest X-ray. Pediatr Radiol 1974;2:97-100.
20. van Woensel JB, Wolfs TF, van Aalderen WM, Brand PL, Kimpen JL. Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis. Thorax 1997;52:634-637.
21. Behrendt CE, Decker MD, Burch DJ, Watson PH. International variation in the management of infants hospitalized with respiratory syncytial virus. International RSV Study Group. Eur J Pediatr 1998;157:215-220.
22. Schroeder AR, Marmor AK, Pantell RH, Newman TB. Impact of pulse oximetry and oxygen therapy on length of stay in bronchiolitis hospitalizations. Arch Pediatr Adolesc Med 2004; 158:527-530.
23. Willson DF, Jiao JH, Hendley JO, Donowitz L. Invasive monitoring in infants with respiratory syncytial virus infection. J Pediatr 1996;128:357-362.
24. Cleophas TJ, Zwinderman AH. Limitations of randomized clinical trials. Proposed alternative designs. Clin Chem Lab Med 2000;38:1217-1223.
25. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 2006;295:1152-1160.
26. Antman EM. Clinical trials in cardiovascular medicine. Circulation 2001;103:E101-E104.
27. Friis B, Andersen P, Brenoe E, Hornsleth A, Jensen A, Knudsen FU, Krasilnikoff PA, Mordhorst CH, Nielsen S, Uldall P. Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child 1984;59:1038-1045.
28. Todd JK. Antibiotics for respiratory syncytial virus infection. Pediatr Infect Dis J 1990;9:754.
29. Diagnosis and management of bronchiolitis. Pediatrics 2006;118: 1774-1793.
30. Hale KA, Isaacs D. Antibiotics in childhood pneumonia. Paediatr Respir Rev 2006;7:145-151.
31. Turner RB, Lande AE, Chase P, Hilton N, Weinberg D. Pneumonia in pediatric outpatients: Cause and clinical manifestations. J Pediatr 1987;111:194-200.
32. McIntosh K. Community-acquired pneumonia in children. N Engl J Med 2002;346:429-437.
33. Jaye DL, Waites KB. Clinical applications of C-reactive protein in pediatrics. Pediatr Infect Dis J 1997;16:735-746.
34. Saijo M, Ishii T, Kokubo M, Murono K, Takimoto M, Fujita K. White blood cell count, C-reactive protein and erytrocyte sedimentation rate in respiratory syncytial virus infection of the lower respiratory tract. Acta Pediatr Jpn 1996;38:596-600.
35. Simpson W, Hacking PM, Court SD, Gardner PS. The radiological findings in respiratory syncytial virus infection in children. II. The correlation of radiological categories with clinical and virological findings. Pediatr Radiol 1974;2:155-160.
36. Eriksson J, Nordshus T, Carlsen KH, Orstadvik I, Westvik J, Eng J. Radiological findings in children with respiratory syncytial virus infection: Relationship to clinical and bacteriological findings. Pediatr Radiol 1986;16:120-122.
37. Farah MM, Padgett LB, McLario DJ, Sullivan KM, Simon HK. First-time wheezing in infants during respiratory syncytial virus season: Chest radiograph findings. Pediatr Emerg Care 2002;18:333-336.
38. van Woensel JB, von R I, Kimpen JL, Spanjaard L, van Aalderen WM. Antibiotic use in pediatric intensive care patients with lower respiratory tract infection due to respiratory syncytial virus. Intensive Care Med 2001;27:1436.
39. Randolph AG, Reder L, Englund JA. Risk of bacterial infection in previously healthy respiratory syncytial virus-infected young children admitted to the intensive care unit. Pediatr Infect Dis J 2004;23:990-9994.
40. Kneyber MC, Blusse vO-A, van VM, Uiterwaal CS, Kimpen JL, van Vught AJ. Concurrent bacterial infection and prolonged mechanical ventilation in infants with respiratory syncytial virus lower respiratory tract disease. Intensive Care Med 2005;31:680-685.
41. Thorburn K, Harigopal S, Reddy V, Taylor N, van Saene HK. High incidence of pulmonary bacterial co-infection in children with severe respiratory syncytial virus (RSV) bronchiolitis. Thorax 2006;61:611-615.
42. Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet 2004;364:803-811.